Filing Details

Accession Number:
0001144204-14-074228
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-16 16:04:46
Reporting Period:
2014-12-12
Filing Date:
2014-12-16
Accepted Time:
2014-12-16 16:04:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1253886 G Patrick Enright C/O Longitude Capital Partners, Llc
800 El Camino Real, Suite 220
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2014-12-12 1,393 $170.32 2,600 No 4 S Direct
Ordinary Shares Disposition 2014-12-12 650 $171.67 1,950 No 4 S Direct
Ordinary Shares Disposition 2014-12-12 300 $172.53 1,650 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 352,928 Indirect By Longitude Venture Partners, L.P.
Ordinary Shares 7,072 Indirect By Longitude Capital Associates, L.P.
Footnotes
  1. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $170.02 to $170.55. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  2. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $171.45 to $172.07. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  3. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $172.48 to $172.63. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  4. The Reporting Person is a managing member of Longitude Capital Partners, LLC, the general partner of each of Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. The Reporting Person disclaims beneficial ownership of the securities of the Issuer held by Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. except to the extent of his pecuniary interest therein.